Of Interest

  • Precision Health User Story: Dan Hertz

    The #UMPrecisionHealth User Story Series debuts with @UMichPharmacy Assistant Prof. Dan Hertz. He explains how the Michigan Genomics Initiative facilitates his research identifying cancer treatment biomarkers and toxicity.

  • COVID-19 Disparities Among Communities of Color

    A $1.4 million grant from the National Institutes of Health Community Engagement Alliance (CEAL) Against COVID-19 Disparities supports work to promote COVID-19 research and inclusivity among African Americans and Hispanic/Latino populations. Communities Conquering COVID, or C3, was launched by Michigan Medicine, MICHR, and the University of Michigan School of Public Health.

  • Next-Generation Sequencing for Patients with Advanced Cancer

    Precision Health member Arul Chinnaiyan was senior author of a study in JAMA Oncology showing the benefits of next-generation tumor sequencing for patients with advanced cancer or cancer of unknown origin. The study examined nearly seven years’ worth of data from 1,015 patients who participated in the Michigan Oncology Sequencing Program (Mi-ONCOSEQ).

Feature Stories